Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data

Affiliations

¹ Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases and Global Health Center, Cincinnati, OH, USA. Electronic address: contact@brightoncollaboration.org.
² Baylor College of Medicine, Department of Pediatrics and Molecular Virology and Microbiology, Houston, TX, USA.
³ ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - University of Barcelona, Barcelona, Spain.
⁴ Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
⁵ Fetal Medicine Unit, St George's Hospital, University of London, UK.
⁶ Fetal Medicine Unit, University Hospital of Leicester, UK.
⁷ Office of Clinical Research Resources, NIAID/NIH, Rockville, MD, USA.
⁸ Aga Khan University, Department of Pediatrics and Child Health, Karachi, Pakistan.
⁹ Sanofi Pasteur, Swiftwater, PA, USA.
¹⁰ Kelly Government Solutions, Contractor to DAIDS/NIAID/NIH, Rockville, MD, USA.
¹¹ Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA.
¹² Global Healthcare Consulting, Delhi, India; Erasmus University Medical Center, Rotterdam, The Netherlands.
¹³ Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases and Global Health Center, Cincinnati, OH, USA.

Guideline

Elizabeth P Schlaudecker et al. Vaccine. 2017.

. 2017 Dec 4;35(48 Pt A):6518-6528.

doi: 10.1016/j.vaccine.2017.01.040.

¹ Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases and Global Health Center, Cincinnati, OH, USA. Electronic address: contact@brightoncollaboration.org.
² Baylor College of Medicine, Department of Pediatrics and Molecular Virology and Microbiology, Houston, TX, USA.
³ ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - University of Barcelona, Barcelona, Spain.
⁴ Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
⁵ Fetal Medicine Unit, St George's Hospital, University of London, UK.
⁶ Fetal Medicine Unit, University Hospital of Leicester, UK.
⁷ Office of Clinical Research Resources, NIAID/NIH, Rockville, MD, USA.
⁸ Aga Khan University, Department of Pediatrics and Child Health, Karachi, Pakistan.
⁹ Sanofi Pasteur, Swiftwater, PA, USA.
¹⁰ Kelly Government Solutions, Contractor to DAIDS/NIAID/NIH, Rockville, MD, USA.
¹¹ Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA.
¹² Global Healthcare Consulting, Delhi, India; Erasmus University Medical Center, Rotterdam, The Netherlands.
¹³ Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases and Global Health Center, Cincinnati, OH, USA.

No abstract available

Keywords: Adverse event; Brighton collaboration; Case definition; GAIA; Guidelines; Maternal immunisation; Small for gestational age.

References

1. de Onis M., Habicht J.P. Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am J Clin Nutr. 1996;64:650–658. - PubMed
1. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1–452. - PubMed
1. Kalagiri R.R., Carder T., Choudhury S., Vora N., Ballard A.R., Govande V. Inflammation in complicated pregnancy and its outcome. Am J Perinatol. 2016 - PubMed
1. PrabhuDas M., Bonney E., Caron K., Dey S., Erlebacher A., Fazleabas A. Immune mechanisms at the maternal-fetal interface: perspectives and challenges. Nat Immunol. 2015;16:328–334. - PMC - PubMed
1. Fest S., Aldo P.B., Abrahams V.M., Visintin I., Alvero A., Chen R. Trophoblast-macrophage interactions: a regulatory network for the protection of pregnancy. Am J Reprod Immunol. 2007;57:55–66. - PubMed